Alpine Immune Sciences, Inc.
Records under this name other than the patents Alpine Immune Sciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 31 patents it holds.
Back to Alpine Immune Sciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,921,562 | Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,673,961 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents Formerly held Lapsed on the fee record Ended Mar 18, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 18, 2026 | From the USPTO record |
| US 9,856,219 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors Formerly held Lapsed on the fee record Ended Jan 2, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 2, 2026 | From the USPTO record |
| US 9,814,700 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents Formerly held Lapsed on the fee record Ended Nov 14, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 14, 2025 | From the USPTO record |
| US 9,498,466 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents Formerly held Lapsed on the fee record Ended Nov 22, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 22, 2024 | From the USPTO record |
| US 9,433,618 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors Formerly held Lapsed on the fee record Ended Sep 6, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 6, 2024 | From the USPTO record |
| US 9,315,462 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors Formerly held Lapsed on the fee record Ended Apr 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 19, 2024 | From the USPTO record |
| US 9,180,119 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents Formerly held Lapsed on the fee record Ended Nov 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 10, 2023 | From the USPTO record |
| US 9,139,528 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors Formerly held Lapsed on the fee record Ended Sep 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 22, 2023 | From the USPTO record |
| US 10,399,946 | Solid forms of an S-Nitrosoglutathione reductase inhibitor Formerly held Lapsed on the fee record Ended Sep 3, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 3, 2023 | From the USPTO record |